Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN)

96 filings reported holding ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q1 2025.
Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 38.4M shares of 79.6M outstanding shares and own 48.28% of the company stock.
Largest 10 shareholders include BVF INC/IL (6.29M shares), RA CAPITAL MANAGEMENT, L.P. (3.57M shares), VANGUARD GROUP INC (2.95M shares), First Light Asset Management, LLC (2.33M shares), SPHERA FUNDS MANAGEMENT LTD. (2.31M shares), Blue Owl Capital Holdings LP (1.82M shares), Woodline Partners LP (1.67M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (1.59M shares), Schonfeld Strategic Advisors LLC (1.32M shares), and Ensign Peak Advisors, Inc (1.26M shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.